pler guidewire. Patients were divided into two groups based on myocardial viability assessed by single-photon emission computed tomographic thallium-201 imaging 6 months after the infarction; 81 patients with viable myocardium and 32 patients with nonviable myocardium. Redistribution patterns or residual maximal myocardial activity >50% are indices of tissue viability. Results: Coronary flow velocity variables showed significantly higher systolic peak velocity (8±20 vs -31±23 cm/s; p=0.0001) and longer DDT (722±196 vs 312±157 ms; p=0.0001) in viable myocardial group compared with nonviable myocardial group. The optimal cutoff values to predict viable myocardium was 0 cm/s for systolic peak velocity and 600ms for DDT (sensitivity=0.85, specificity=0.94 and sensitivity=0.93, specificity=0.91, respectively). Conclusion: These data suggest that the CFV pattern is an accurate predictor of the presence or absence of residual myocardial viability at the late stage in patients with anterior AMI.
We tested whether reduced shear stress (SS) and large shear stress gradient could be caused coronary artery aneurysm (AN) formation at coronary branching site and thrombus formation in AN in patients with Kawasaki disease (KD). 139 children (2y -16y) who had coronary abnormality revealed by 2-D echo were subjected. All patients had different sized AN without any significant stenosis in proximal and distal portion of AN and were divided into four groups by the maximum diameter of AN; Group S: < 1.5-fold the diameter of the adjacent normal-looking vessel, n=34, Group M:1.5 </= to < 4.0-fold, n=31, Group L: </= 4.0-hold, n=29, Group N: normal-looking vessels by CAG, n=45. All patients had Aspirin and / or Warfarin. The averaged peak velocity (APV) was measured at the middle of ANs in groups L, M and S, at the branching site of segment 5-6-11 in group N, and at the normal-looking proximal lesion of AN in all 4 groups. SS was calculated by the simplified formula as: shear stress = 4µAPV/(R/2), where µ is blood viscosity, R is maximum inner diameter of AN or coronary vessel. SS gradient was calculated by the formula as: SS gradient = SS at normal-looking lesion / SS at AN or coronary branching site. Also, CAG and IVUS were performed for detection of thrombus and localization of ANs.Results:* p < 0.05 vs. groups M, S. SS in normal-looking vessels were 26.6 ± 3.1
Conclusions:
Reduced shear stress and large shear stress gradient may play a critical role of giant aneurysm and thrombus formation intra coronary aneurysms in Kawasaki disease.
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Physiologic Background: The American Heart Association (AHA) has recently classified obesity as a modifiable risk factor for coronary heart disease. Therefore, we evaluated the impact of obesity on insulin resistance and coronary endothelial function in overweight patients with normal or mild coronary artery disease. Methods: A total of 32 consecutive non-diabetic patients with normal or mildly diseased coronary arteries at angiography underwent coronary vascular reactivity evaluation using intracoronary administration of papaverine, acetylcholine and nitroglycerin using a Doppler guidewire. Patients were divided into two groups based on body mass index (BMI): Group 1, patients with a BMI<25 (n = 19, normal weight); and Group 2, patients with a BMI>25 (n = 13, overweight). The level of fasting immunoreactive insulin (FIRI) and fasting blood glucose (FBS) were measured in each subject. Homeostasis model assessment (HOMA-R) was used as an indicator of insulin resistance. Results: FIRI and HOMA-R in Group 2 were significantly greater than those in Group 1 (4.4±2.7 vs. 14.5±7.4 µU/ml, p<0.01; 1.02±0.62 vs. 3.52±1.77, p<0.01, respectively), whereas FBS was similar when comparing the two groups (95±11 vs. 98±13 mg/dl). The percent change in coronary blood flow and coronary artery diameter induced by acetylcholine in Group 2 had a significant negative correlation with both HOMA-R and FIRI (HOMA-R:r=-0. Background: Coronary stenting is a known, potent stimulator of adventitial angiogenesis.These post stent angiogenesis may help neointimal growth and maintenance. Cell migration and proliferation blockage are two known mechanism of Paclitaxel limiting neointimal hiperplasia. Paclitaxel is a known angiogenesis inhibitor in other tissues, like tumors, nonentheless this effect on coronary arteries has not been yet studied. We thus examined adventitial neovascularization in porcine coronary arteries following paclitaxel eluting stent implant and compared them with control stents. Methods: Forty-three stented arteries, 26 paclitaxel stents (1ug/mm 2 ) and 17 controls were examined blindly. Adventitial vessels (vasa vasorum) were identified as arterial structures with endothelial cells surrounding a lumen, with or without erythrocytes. Adventitial vessel density was determined by manual counting using a curved geometric shape 400x50 microns placed in the adventitia, bordering the external elastic lamina. Intimal thickness was measured from the back of each strut to the lumen and calculated an average for each artery. Results: Paclitaxel-stented arteries showed a marked decrease in adventitial vessels compared with control stented vessels (1.5+1.2 versus 3.1 + 2.2 vessels/20,000 sq microns, p<0.003). There was no statistical difference in minimum intima thickness between the treated and control groups in this mild injury model (paclitaxel: 308.9 + 57.3, controls: 284.9 + 59.0 microns, p>0.5). Conclusions: Paclitaxel elution from stents is associated with markedly decreased adventitial angiogenesis. In addition to its anti migratory and antiproliferative effects, paclitaxel may prevent neointimal growth by preventing adventitial vasa vasorum, limiting oxygen and nutrient supply to the neointima. If true, this opens novel therapeutic strategies for limiting neointimal hyperplasia.
1158-52
Proteomic Restenosis is the major limiting factor of balloon angioplasty.Identifying genes that regulate neointima formation is ongoing, facilitated by cDNA array profiling of the arterial wall. This study utilizes proteomic profiling to identify gene products involved in arterial remodeling that occurs as a consequence of restenosis. We specifically identified proteins inhibited by rapamycin since this drug is being used clinically for its anti-restenotic properties. Intramural infusion of rapamycin or its vehicle was delivered through a balloon catheter directly into the vessel wall during angioplasty. After 3 weeks, proteomic profiles of arterial wall segments were obtained. 
